Literature DB >> 18553401

Epidermal growth factor promotes breast cancer cell chemotaxis in CXCL12 gradients.

Bobak Mosadegh1, Wajeeh Saadi, Shur-Jen Wang, Noo Li Jeon.   

Abstract

The chemokine receptor CXCR4 and its ligand CXCL12 play an important role in breast cancer invasion and metastasis, and induce the chemotaxis of various types of cancer cells. Previous studies of CXCL12-induced chemotaxis have, for the most part, relied on endpoint assays (e.g., transwell assays) that provide poor control over the cell microenvironment. Specifically, these assays lacked the ability to dissect the role that autocrine and paracrine growth factors play in chemokine-induced cancer cell chemotaxis. Here, we employ a microfluidic chemotaxis chamber that allows the effects of specific exogenous factors on cell migration to be directly characterized, without the interference of autocrine/paracrine signaling. Using this approach, we investigated the migration of MDA-MB-231 breast cancer cells in well-defined CXCL12 gradients. We found that CXCL12 alone failed to stimulate chemotaxis of these cells; however, when the CXCL12 gradient was supplemented with a uniform stimulus of either EGF or conditioned media, a directional response was induced. This dependence on growth factor signaling points to the importance of autocrine and paracrine factors in determining the migratory response of the cells, and may play an important role in cancer metastasis. 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18553401     DOI: 10.1002/bit.21851

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  26 in total

Review 1.  Quantitative analysis of gradient sensing: towards building predictive models of chemotaxis in cancer.

Authors:  Shannon K Hughes-Alford; Douglas A Lauffenburger
Journal:  Curr Opin Cell Biol       Date:  2012-01-26       Impact factor: 8.382

2.  Microfluidic platform for chemotaxis in gradients formed by CXCL12 source-sink cells.

Authors:  Yu-Suke Torisawa; Bobak Mosadegh; Tommaso Bersano-Begey; Jessica M Steele; Kathryn E Luker; Gary D Luker; Shuichi Takayama
Journal:  Integr Biol (Camb)       Date:  2010-09-27       Impact factor: 2.192

3.  Vagrant stem cells draft their gene companions.

Authors:  Halvard Bonig; Thalia Papayannopoulou
Journal:  Cell Stem Cell       Date:  2010-11-05       Impact factor: 24.633

4.  Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.

Authors:  Ulrike Haessler; Marco Pisano; Mingming Wu; Melody A Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

5.  Microfluidics-based devices: New tools for studying cancer and cancer stem cell migration.

Authors:  Yu Huang; Basheal Agrawal; Dandan Sun; John S Kuo; Justin C Williams
Journal:  Biomicrofluidics       Date:  2011-03-30       Impact factor: 2.800

6.  Bi-ligand surfaces with oriented and patterned protein for real-time tracking of cell migration.

Authors:  Varadraj N Vernekar; Charles S Wallace; Mina Wu; Joshua T Chao; Shannon K O'Connor; Aimee Raleigh; Xiaji Liu; Jason M Haugh; William M Reichert
Journal:  Colloids Surf B Biointerfaces       Date:  2014-09-19       Impact factor: 5.268

Review 7.  Microfluidics for mammalian cell chemotaxis.

Authors:  Beum Jun Kim; Mingming Wu
Journal:  Ann Biomed Eng       Date:  2011-12-22       Impact factor: 3.934

8.  Spontaneous migration of cancer cells under conditions of mechanical confinement.

Authors:  Daniel Irimia; Mehmet Toner
Journal:  Integr Biol (Camb)       Date:  2009-07-16       Impact factor: 2.192

9.  Three-dimensional paper-based model for cardiac ischemia.

Authors:  Bobak Mosadegh; Borna E Dabiri; Matthew R Lockett; Ratmir Derda; Patrick Campbell; Kevin Kit Parker; George M Whitesides
Journal:  Adv Healthc Mater       Date:  2014-02-12       Impact factor: 9.933

10.  EGF as a New Therapeutic Target for Medulloblastoma Metastasis.

Authors:  Jennifer Rico-Varela; Tanya Singh; Sean McCutcheon; Maribel Vazquez
Journal:  Cell Mol Bioeng       Date:  2015-06-04       Impact factor: 2.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.